Progressive disruption of neurodevelopment by mid‐gestation exposure to lipopolysaccharides and the ameliorating effect of continuous alpha‐glycosyl isoquercitrin treatment

Abstract

We investigated the effect of lipopolysaccharide (LPS)-induced maternal immune activation used as a model for producing neurodevelopmental disorders on hippocampal neurogenesis and behaviors in rat offspring by exploring the antioxidant effects of alpha-glycosyl isoquercitrin (AGIQ). Pregnant Sprague-Dawley rats were intraperitoneally injected with LPS (50 μg/kg body weight) at gestational days 15 and 16. AGIQ was administered in the diet to dams at 0.5% (w/w) from gestational day 10 until weaning at postnatal day 21 and then to offspring until adulthood at postnatal day 77. During postnatal life, offspring of LPS-injected animals did not show neuroinflammation or oxidative stress in the brain. At weaning, LPS decreased the numbers of type-2b neural progenitor cells (NPCs) and PCNA + proliferating cells in the subgranular zone, FOS-expressing granule cells, and GAD67 + hilar interneurons in the dentate gyrus. In adulthood, LPS decreased type-1 neural stem cells, type-2a NPCs, and GAD67 + hilar interneurons, and downregulated Dpysl3, Sst, Fos, Mapk1, Mapk3, Grin2a, Grin2b, Bdnf, and Ntrk2. In adults, LPS suppressed locomotor activity in the open field test and suppressed fear memory acquisition and fear extinction learning in the contextual fear conditioning test. These results indicate that midgestation LPS injections disrupt programming of normal neurodevelopment resulting in progressive suppression of hippocampal neurogenesis and synaptic plasticity of newborn granule cells by suppressing GABAergic and glutamatergic neurotransmitter signals and BDNF/TrkB signaling to result in adult-stage behavioral deficits. AGIQ ameliorated most aberrations in hippocampal neurogenesis and synaptic plasticity, as well as behavioral deficits. Effective amelioration by continuous AGIQ treatment starting before LPS injections may reflect both anti-inflammatory and anti-oxidative stress effects during gestation and neuroprotective effects of continuous exposure through adulthood.

SARS-CoV-2 (COVID-19) as a possible risk factor for neurodevelopmental disorders

“…There is a rich body of literature demonstrating that pro-inflammatory cytokines disrupt neurogenesis in the adult rodent hippocampus [see (Kim et al, 2016) for review] and several MIA studies examined adult hippocampal neurogenesis. Mid-gestation MIA (LPS) suppressed hippocampal neurogenesis in adult rat (Okano et al, 2022), as did late gestation treatment with Poly(I:C) (Zhao et al, 2019), while suppression of maternal IL-6 enhanced it (Mouihate and Kalakh, 2021). Finally, defective neurogenesis in the subventricular zone (SVZ)-olfactory bulb (OB) pathway has been reported following early gestational exposure to Poly:I:C in mouse (Liu et al, 2013).…”